Enter Akili Interactive. After struggling with vying for insurance coverage of EndeavorRX, a video game-based treatment for ADHD; pivoting away from the PDT model, and cutting 40% of its staff in ...

Akili, the company behind video game-like prescription and over-the-counter digital therapeutics for individuals with ADHD, has signed a definitive merger agreement with mental health and fitness ...

After announcing it would start selling its assets earlier this year and lay off nearly half the company, the medical app developer Akili Interactive has found a willing buyer. Virtual Therapeutics, ...

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal ...

Akili Interactive is kicking off 2023 with the goal of shrinking its operational footprint and cutting costs to help expand the commercial reach of its digital therapeutics—a trade-off that will cost ...

The Roblox vision for bringing people together through shared experiences, plus the Akili commitment to a new era of cognitive medicine, make the companies ideal partners to deliver a reimagined ...

Akili Interactive, which in 2020 made waves by receiving Food and Drug Administration clearance for its video game that improves symptoms of ADHD in children, on Wednesday announced it would reorient ...

The team at Akili describes its ethos on its website as “establishing a new era of cognitive medicine.” The company writes it “[believes] effective medicine can also be fun and engaging [by] creating ...